{
    "clinical_study": {
        "@rank": "28530", 
        "acronym": "ArtAssist", 
        "arm_group": [
            {
                "arm_group_label": "Art Assist Device", 
                "arm_group_type": "Active Comparator", 
                "description": "The ArtAssist\u00a9 (model AA1000) device is made by ACI Medical located in San Marcos, CA (http://acimedical.com/) and is cleared per FDA under K942530.The study intervention will consist of one hour of IPC with the ArtAssist\u00a9 device to the remaining leg, three times a day for a three month period. We will obtain the usage data from the device when the subject returns the device (the device has an internal device that stores the usage data) to evaluate subject compliance."
            }, 
            {
                "arm_group_label": "Sham Device", 
                "arm_group_type": "Sham Comparator", 
                "description": "Sham devices look identical to the actual ArtAssist\u00a9 devices, but provide low-pressure and differ only in number-coded tubing.  The study \"sham intervention\" will consist of one hour of IPC with the sham ArtAssist\u00a9 device to the remaining leg, three times a day for a three month period. We will obtain the usage data from the device when the subject returns the device (the sham device has an internal device that stores the usage data) to evaluate subject compliance."
            }
        ], 
        "brief_summary": {
            "textblock": "In this clinical research study the investigators will test the efficacy of an innovative,\n      non-invasive methodology to reduce mortality and lower limb loss among high-risk\n      medically-underserved patients with cardiovascular disease in North Philadelphia.\n\n      Patients with cardiovascular disease and recent lower limb amputation will be treated with\n      an intermittent compression device on the remaining lower limb to prevent dual amputation.\n\n      The study hypothesis is that the study intervention will protect against further lower\n      limb-loss/death and reduce cardiovascular mortality in these patients (one year effect\n      against limb-loss/death).\n\n      This study may result in better secondary prevention strategies for disadvantaged urban\n      populations as well as the general population."
        }, 
        "brief_title": "External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality", 
        "completion_date": {
            "#text": "February 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Amputation of Lower Limb", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and Female ages \u2265 21years old\n\n          -  Able and willing to provide informed consent\n\n          -  Status post amputation of lower limb\n\n          -  IPC treatment can be initiated within 30 days post lower limb amputation\n\n          -  Ankle-brachial index in the remaining extremity of less than 0.80, or toe-\n                 brachial index less than 0 .60 (obtained within last 6 months)\n\n          -  Patients must be able to sit and able to perform the compression  therapy\n             independently\n\n          -  Intact renal function or if patient has chronic kidney disease a pre study\n             Creatinine will be obtained. If the patient has acute renal failure or is a dialysis\n             patient he/she is eligible, but will be separately randomized and analyzed because\n             Creatinine is linked to survival.\n\n               -  Subjects status post healed minor (toe/metatarsal) amputations on treatment leg\n                  will be included.\n\n        Exclusion Criteria:\n\n          -  Patients who have no demonstrable peripheral artery disease by ankle-pressure and/or\n             toe-pressure in the remaining limb (initial amputations were mostly precipitated by\n             diabetic neuropathy, deformity, infection, or acute embolization.  Amputations\n             resulting from the late effects of trauma, burns, frostbite, etc. are also excluded.\n\n          -  Patients who are not able to consent due to their mental status, or who are not\n             willing or able to perform the compression therapy in a sitting position\n\n          -  Contracted nursing-home patients with index amputations resulting from largely\n             pressure-related tissue-loss decubitus\n\n          -  Patients with infected gangrene or osteomyelitis present in the contra-lateral\n             extremity (which would need to be compressed) at the time of the index amputation\n\n          -  Patients with active dry gangrene on the leg that is to be compressed\n\n          -  Patients with congestive heart failure\n\n          -  Patients in which a deep venous thrombosis or pulmonary embolism is suspected\n\n          -  Patients who have undergone arterial compression therapy within 1 year prior to study\n\n          -  Bilateral amputation of lower extremity\n\n          -  Patients with an expected life-span less than 3 months\n\n          -  Patients who require intensive care are not eligible, until they can be transferred\n             to a regular nursing floor\n\n          -  Patients in whom the remaining limb is non-functional, for example due to previous\n             stroke"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02054416", 
            "org_study_id": "PVB012013"
        }, 
        "intervention": {
            "arm_group_label": [
                "Art Assist Device", 
                "Sham Device"
            ], 
            "description": "The study intervention will consist of one hour of IPC with the ArtAssist\u00a9 device to the remaining leg, three times a day for a three month period. We will obtain the usage data from the device when the subject returns the device (the device has an internal device that stores the usage data) to evaluate subject compliance.", 
            "intervention_name": "ArtAssist\u00a9 Device", 
            "intervention_type": "Device", 
            "other_name": "The ArtAssist\u00a9 (model AA1000) device is made by ACI Medical located in San Marcos, CA (http://acimedical.com/) and is cleared per FDA under K942530."
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "non-traumatic lower limb amputation", 
            "AKA", 
            "BKA"
        ], 
        "lastchanged_date": "February 3, 2014", 
        "location": {
            "contact": {
                "email": "paul.vanBemmelen@tuhs.temple.edu", 
                "last_name": "Paul van Bemmelen, MD, PhD", 
                "phone": "215-707-3622"
            }, 
            "contact_backup": {
                "email": "marian.debacker@tuhs.temple.edu", 
                "last_name": "Marian De Backer, RN, BSN", 
                "phone": "215-707-7143"
            }, 
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19140"
                }, 
                "name": "Temple University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality in Underserved Philadelphia Patient Population: A Randomized Controlled Study", 
        "overall_contact": {
            "email": "Paul.vanBemmelen@tuhs.temple.edu", 
            "last_name": "Paul van Bemmelen, MD, PhD", 
            "phone": "215-707-3622"
        }, 
        "overall_contact_backup": {
            "email": "marian.debacker@tuhs.temple.edu", 
            "last_name": "Marian De Backer, RN, BSN", 
            "phone": "215-707-7143"
        }, 
        "overall_official": {
            "affiliation": "Temple University", 
            "last_name": "Paul van Bemmelen, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Amputation free survival", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02054416"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Temple University", 
            "investigator_full_name": "Paul van Bemmelen", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Temple University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Temple University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}